Reference
[1] S. Tsai, X. Clemente-Casares, P. Santamaria, CD8(+) Tregs in autoimmunity: learning ”self”-control from experience, Cell Mol Life Sci 68(23) (2011) 3781-95.
[2] S. Mishra, S. Srinivasan, C. Ma, N. Zhang, CD8(+) Regulatory T Cell - A Mystery to Be Revealed, Front Immunol 12 (2021) 708874.
[3] A.R. Schenkel, L.C. Kingry, R.A. Slayden, The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infection, Front Immunol 4 (2013) 90.
[4] C. Viant, A. Fenis, G. Chicanne, B. Payrastre, S. Ugolini, E. Vivier, SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells, Nat Commun 5 (2014) 5108.
[5] H. Zhu, M. Zhao, C. Chang, V. Chan, Q. Lu, H. Wu, The complex role of AIM2 in autoimmune diseases and cancers, Immun Inflamm Dis 9(3) (2021) 649-665.
[6] M. Yang, D. Long, L. Hu, Z. Zhao, Q. Li, Y. Guo, Z. He, M. Zhao, L. Lu, F. Li, H. Long, H. Wu, Q. Lu, AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation, Signal Transduct Target Ther 6(1) (2021) 341.
[7] D. Verma, S.Z. Fekri, G. Sigurdardottir, C. Bivik Eding, C. Sandin, C. Enerbäck, Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation, J Invest Dermatol 141(3) (2021) 586-595.e5.
[8] Y. Chen, Q. Fujuan, E. Chen, B. Yu, F. Zuo, Y. Yuan, X. Zhao, C. Xiao, Expression of AIM2 in Rheumatoid Arthritis and Its Role on Fibroblast-Like Synoviocytes, Mediators Inflamm 2020 (2020) 1693730.
[9] A.G. Vakrakou, I.P. Svolaki, K. Evangelou, V.G. Gorgoulis, M.N. Manoussakis, Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren’s syndrome, J Autoimmun 108 (2020) 102381.
[10] G. Guggino, D. Mauro, A. Rizzo, R. Alessandro, S. Raimondo, A.S. Bergot, M.A. Rahman, J.J. Ellis, S. Milling, R. Lories, D. Elewaut, M.A. Brown, R. Thomas, F. Ciccia, Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis, Arthritis Rheumatol 73(7) (2021) 1189-1199.
[11] M. Zhang, C. Jin, Y. Yang, K. Wang, Y. Zhou, Y. Zhou, R. Wang, T. Li, R. Hu, AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway, J Cell Physiol 234(11) (2019) 20161-20173.
[12] J.E. Wilson, A.S. Petrucelli, L. Chen, A.A. Koblansky, A.D. Truax, Y. Oyama, A.B. Rogers, W.J. Brickey, Y. Wang, M. Schneider, M. Mühlbauer, W.C. Chou, B.R. Barker, C. Jobin, N.L. Allbritton, D.A. Ramsden, B.K. Davis, J.P. Ting, Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt, Nat Med 21(8) (2015) 906-13.
[13] R.E. Dawson, V. Deswaerte, A.C. West, K. Tang, A.J. West, J.J. Balic, L.J. Gearing, M.I. Saad, L. Yu, Y. Wu, P.S. Bhathal, B. Kumar, J.T. Chakrabarti, Y. Zavros, H. Oshima, D.M. Klinman, M. Oshima, P. Tan, B.J. Jenkins, STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis, Gut (2021).
[14] W.C. Chou, Z. Guo, H. Guo, L. Chen, G. Zhang, K. Liang, L. Xie, X. Tan, S.A. Gibson, E. Rampanelli, Y. Wang, S.A. Montgomery, W.J. Brickey, M. Deng, L. Freeman, S. Zhang, M.A. Su, X. Chen, Y.Y. Wan, J.P. Ting, AIM2 in regulatory T cells restrains autoimmune diseases, Nature 591(7849) (2021) 300-305.
[15] R. Gandhi, D. Kumar, E.J. Burns, M. Nadeau, B. Dake, A. Laroni, D. Kozoriz, H.L. Weiner, F.J. Quintana, Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells, Nat Immunol 11(9) (2010) 846-53.
[16] H.J. Kim, R.A. Barnitz, T. Kreslavsky, F.D. Brown, H. Moffett, M.E. Lemieux, Y. Kaygusuz, T. Meissner, T.A. Holderried, S. Chan, P. Kastner, W.N. Haining, H. Cantor, Stable inhibitory activity of regulatory T cells requires the transcription factor Helios, Science 350(6258) (2015) 334-9.
[17] S. Mishra, W. Liao, Y. Liu, M. Yang, C. Ma, H. Wu, M. Zhao, X. Zhang, Y. Qiu, Q. Lu, N. Zhang, TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells, J Exp Med 218(1) (2021).